QD 232
QD 232 is a quinazolinedione-based ROS inducer and an apoptosis inducer with cytotoxicity and redox regulatory activity. QD 232 promotes ROS accumulation, activates the NRF2-mediated oxidative stress response and unfolded protein response pathways, and upregulates downstream antioxidant and stress response genes. QD 232 inhibits mtDNA transcription driven by HSP2 and LSP promoters, and impairs mitochondrial oxidative phosphorylation function. QD 232 induces apoptosis of pancreatic ductal adenocarcinoma cells and exerts cytotoxicity against gemcitabine (HY-17026)-resistant pancreatic ductal adenocarcinoma cells. QD 232 delays tumor growth in a mouse pancreatic cancer xenograft model.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1527467-32-8
- 分子式: C16H11N3O3
- 分子量:293.28
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示
More
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BXPC-3 | IC50 |
5.2 μM
Compound: QD 232
|
Cytotoxicity against human BxPC3 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human BxPC3 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
|
[PMID: 29328656] |
| MIA PaCa-2 | IC50 |
2.3 μM
Compound: QD 232
|
Cytotoxicity against human MIAPaCa2 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human MIAPaCa2 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
|
[PMID: 29328656] |
| MIA PaCa-2 | IC50 |
3.6 μM
Compound: QD 232
|
Cytotoxicity against gemcitabine-resistant human MIAPaCa2 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
Cytotoxicity against gemcitabine-resistant human MIAPaCa2 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
|
[PMID: 29328656] |
| PANC-1 | IC50 |
0.9 μM
Compound: QD 232
|
Cytotoxicity against human PANC1 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human PANC1 cells assessed as decrease in cell proliferation after 72 hrs by MTT assay
|
[PMID: 29328656] |
QD 232 (30 nM - 10 μM; 72 h) inhibits proliferation of MIA PaCa-2, Panc-1, and BxPC-3 PDAC cell lines with IC50 values of 2.3 μM, 0.9 μM, and 5.2 μM, respectively[1].
QD 232 (30 nM - 10 μM; 72 h) inhibits proliferation of gemcitabine-resistant MIA PaCa-2-GR cells and normal HPDE pancreatic cells with IC50 values of 3.6 μM and 4.5 μM, respectively[1].
QD 232 (30 nM - 10 μM; 72 h) has its proliferation inhibitory effect in MIA PaCa-2 cells attenuated by pretreatment with 5 mM NAC (HY-B0215)[1].
QD 232 treatment induces time-dependent increases in CHOP and GRP78 protein levels in MIA PaCa-2, Panc-1, and BxPC-3 cells, upregulates HO-1 protein in MIA PaCa-2 and BxPC-3 cells, and does not induce NQO1 protein in MIA PaCa-2 and BxPC-3 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MIA PaCa-2, Panc-1, BxPC-3 pancreatic ductal adenocarcinoma (PDAC) cell lines
-
Concentration:30 nM - 10 μM
-
Incubation Time:72 h
-
Result:Inhibited cell proliferation with IC50 values of 2.3 μM in MIA PaCa-2 cells, 0.9 μM in Panc-1 cells, and 5.2 μM in BxPC-3 cells.
-
Cell Line:gemcitabine-resistant MIA PaCa-2-GR PDAC cell line and HPDE normal pancreatic cell line
-
Concentration:30 nM - 10 μM
-
Incubation Time:72 h
-
Result:Inhibited cell proliferation with an IC50 of 3.6 μM in MIA PaCa-2-GR cells and 4.5 μM in HPDE cells.
-
Cell Line:MIA PaCa-2 PDAC cell line
-
Concentration:30 nM - 10 μM; 5 mM NAC (pretreatment)
-
Incubation Time:72 h
-
Result:Attenuated the proliferation inhibitory effect of QD 232 when cells were pretreated with 5 mM NAC, though protection was not complete.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NOD/SCID mice with Pancreatic ductal adenocarcinoma (6-week-old)[1]
-
Dosage:20 mg/kg
-
Administration:5 days on/two days off cycles; 31 days
-
Result:Suppressed tumor growth by 65% over the 31-day study period.
化学情報
-
CAS 番号 1527467-32-8
-
分子量 293.28
-
分子式 C16H11N3O3
-
SMILES
O=C1C=C(NC2=CC=CC(=C2)C(=O)C)C(=O)C=3C=NC=NC13
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)